logo

For the Inventor, By the Inventor

Bottmingen, Switzerland

Rudolf Ruegg

USPTO Granted Patents = 17

Average Co-Inventor Count = 2.6

ph-index = 7

Forward Citations = 189(Granted Patents)


Company Filing History:

goldMedal17 out of 4,945 
 
Hoffmann-la Roche Inc.
 patents

Years Active: 1976-1987

Loading Chart...
17 patents (USPTO):Explore Patents
1. 4656310 - Substituted triarylphosphonium derivatives (1987-04-07),
2. 4532355 - Substituted triaryl phosphonium derivatives (1985-07-30),
3. 4439629 - Extraction process for beta-carotene (1984-03-27),
4. 4319048 - Certain 6-(3'-methoxyphenyl) derivatives of 2,4-hexadienal (1982-03-09),
5. 4267382 - 2,6-Dichloro-4-methoxy-5-methyl-benzene aldehydes (1981-05-12),
6. 4225527 - Polyene compounds (1980-09-30),
7. 4224244 - 9-Phenyl 5,6-dimethyl-nona-2,4,6,8 tetraenal or tetraenol derivatives (1980-09-23),
8. 4215215 - 9-Phenyl-nonate traene compounds (1980-07-29),
9. 4187247 - 9-Substituted phenyl-3,7-dimethyl-nona 2,4,6,8-tetraene compounds (1980-02-05),
10. 4163103 - Novel derivatives of 9-substituted (1979-07-31),
11. 4107190 - Novel compounds of 9-phenyl-3,7-dimethyl-2,4,6,8-nonatetraenamide (1978-08-15),
12. 4105681 - 9-Phenyl 5,6-dimethyl-nona-2,4,6,8-tetraeonic acid compounds (1978-08-08),
13. 4054589 - Novel 9-substituted phenyl-3,7-dimethyl-nona-2,4,6,8-tetraene esters (1977-10-18),
14. 4021574 - Antidandruff compositions containing 9-(4-lower (1977-05-03),
15. 3989758 - Monoacetals of unsaturated aliphatic dialdehydes (1976-11-02),

Title: Rudolf Ruegg: A Pioneer in Anti-Tumor Research

Introduction

Rudolf Ruegg, a prominent inventor based in Bottmingen, Switzerland, has made significant contributions to the field of medicinal chemistry. With an impressive portfolio of 17 patents, his work centers around innovative compounds that could potentially transform cancer treatment.

Latest Patents

Among his latest patents, Rudolf has developed novel substituted triarylphosphonium derivatives, specifically focusing on 9-phenyl 5,6-dimethyl-nona-2,4,6,8-tetraenoic acid, as well as tetraenal and tetraenol derivatives. These compounds show promising applications as anti-tumor agents, paving the way for new therapies in cancer management.

Career Highlights

Rudolf Ruegg's career has been closely tied to Hoffmann-La Roche Inc., a company renowned for its commitment to healthcare innovation. His dedication to research and development has positioned him as a key figure within the organization, where he continues to explore groundbreaking solutions in drug discovery.

Collaborations

Throughout his career, Rudolf has had the opportunity to collaborate with notable professionals such as Werner Bollag and Gottlieb Ryser. These partnerships have amplified his innovative efforts, leading to advancements in therapeutic strategies against cancer.

Conclusion

Rudolf Ruegg's work exemplifies the spirit of innovation in the field of anti-cancer research. His contributions through patents and collaboration with esteemed colleagues reflect his ongoing commitment to improving therapeutic options and advancing medical science. As he continues his journey at Hoffmann-La Roche Inc., the impact of his inventions holds great promise for future developments in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…